PubRank

Junichi Tazaki

Author PubWeight™ 23.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical impact of left ventricular outflow tract obstruction in takotsubo cardiomyopathy. Circ J 2015 1.95
2 Impact of angiosome-oriented revascularization on clinical outcomes in critical limb ischemia patients without concurrent wound infection and diabetes. J Endovasc Ther 2014 1.51
3 Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. Rheumatology (Oxford) 2013 1.12
4 Contemporary outcomes after endovascular treatment for aorto-iliac artery disease. Circ J 2012 1.07
5 Impact of CYP2C19 polymorphisms on the antiplatelet effect of clopidogrel in an actual clinical setting in Japan. Circ J 2009 0.94
6 Acid-insoluble human dentin as carrier material for recombinant human BMP-2. J Biomed Mater Res A 2011 0.93
7 Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2. Circ Cardiovasc Interv 2014 0.92
8 Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population. Am J Hum Genet 2013 0.91
9 Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol 2012 0.89
10 Long-term outcomes of endovascular therapy for aortoiliac bifurcation lesions in the real-AI registry. J Endovasc Ther 2014 0.87
11 Biodegradation and bioabsorption innovation of the functionally graded bovine bone-originated apatite with blood permeability. J Biomed Mater Res A 2006 0.86
12 Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Circ Cardiovasc Interv 2012 0.85
13 Clopidogrel resistance in Japanese patients scheduled for percutaneous coronary intervention. Circ J 2008 0.85
14 β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure. Int J Cardiol 2012 0.82
15 Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis. Heart Vessels 2012 0.82
16 Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy. J Atheroscler Thromb 2012 0.81
17 Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI/CABG registry cohort-2. Circ Cardiovasc Interv 2012 0.81
18 Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan. Cardiovasc Interv Ther 2011 0.80
19 Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world. Circ J 2011 0.79
20 Prognostic Factors in Hemodialysis Patients Undergoing Endovascular Treatment for Critical Limb Ischemia due to Isolated Below-the-Knee Disease. J Atheroscler Thromb 2014 0.78
21 Impact of Diabetes Mellitus on Critical Limb Ischemia With Below the Knee Disease: Japan Below-the-Knee Artery Treatment Subanalysis. Angiology 2013 0.78
22 Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease. Heart Vessels 2014 0.77
23 Stent angioplasty for a kink in the pulmonary artery anastomosis soon after living-donor lobar lung transplantation. Ann Thorac Surg 2011 0.77
24 Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia. Cardiovasc Interv Ther 2013 0.76
25 Influence of initial acute myocardial infarction presentation on the outcome of surgical procedures after coronary stent implantation: a report from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Cardiovasc Interv Ther 2012 0.76
26 Patient-Specific Three-Dimensional Aortocoronary Model for Percutaneous Coronary Intervention of a Totally Occluded Anomalous Right Coronary Artery. J Invasive Cardiol 2015 0.76
27 β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction. Cardiovasc Interv Ther 2012 0.76
28 Successful Management of Guidewire Kinking in a Patient With Subaortic Septal Bulging Using the Pull-Through Technique During Transapical Transcatheter Aortic Valve Implantation. Circ J 2015 0.75
29 Efficacy of the S.M.A.R.T. Control vs. other stents for aortoiliac occlusive disease in contemporary clinical practice. J Endovasc Ther 2013 0.75
30 Association of the use of proton pump inhibitors with adverse cardiovascular and bleeding outcomes after percutaneous coronary intervention in the Japanese real world clinical practice. Cardiovasc Interv Ther 2011 0.75
31 Long-term efficacy and safety outcomes after unrestricted use of drug-eluting stents in patients with acute coronary syndrome: mortality and major bleeding in a single-center registry. Circ J 2014 0.75
32 [Feasibility and possibility of Inoue stent graft for thoracic aortic aneurysms]. Kyobu Geka 2011 0.75
33 Long-term clinical outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease. Cardiovasc Interv Ther 2014 0.75